Recently, TG Therapeutics (TGTX) reported positive results from its Phase 2b registrational directed trial UNITY-NHL study. Updated results from this study were presented at AACR earlier this year, … [Read more...] about The Next Catalyst for TG Therapeutics
TG Therapeutics
ALERT: This Stock Has Been Beat Up, But Could Jump at ASCO
The summer oncology conferences are drawing nearer, and so to is the abstract release date for ASCO. For a complete overview of the timeline and abstract titles I am watching, check out my previous … [Read more...] about ALERT: This Stock Has Been Beat Up, But Could Jump at ASCO
Three Things to Know Going Into TG Therapeutic’s AAN Presentation
The American Academy of Neurology (AAN) annual meeting kicks off this weekend, and runs May 4th through the 10th. In March, TG Therapeutics (TGTX) announced the presentation of data from its ongoing … [Read more...] about Three Things to Know Going Into TG Therapeutic’s AAN Presentation
An In-Depth Assessment Of TG Therapeutics
You voted and we heard you. After my initial article on a few noteworthy results from AACR 2019, we asked you the subscribers to choose one of the four companies that you would like to learn more … [Read more...] about An In-Depth Assessment Of TG Therapeutics
Eye-Catching Results at AACR 2019: A Quick Road Map
In a new series for MS Money Moves Premium Members, Chris Stang a PharmD candidate at the University of Findlay and Nationwide Pharmacy Intern will evaluate a few pieces of data releases from health … [Read more...] about Eye-Catching Results at AACR 2019: A Quick Road Map
You must be logged in to post a comment.